Neuropathic Pain Clinical Trials 2022

Browse 81 Neuropathic Pain Medical Studies Across 163 Cities

9 Phase 3 Trial · 292 Neuropathic Pain Clinics

Reviewed by Michael Gill, B. Sc.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Transcranial Magnetic Stimulationfor Chronic Pain

New York, NY
18+
All Sexes
Around 80% of people with spinal cord injury (SCI) develop chronic neuropathic pain (CNP). This is a debilitating condition with major negative impacts on people's quality of life. Many treatment options have been offered (invasive stimulation, drugs) but provide limited effects and many secondary effects. There is a critical need to develop a new generation of therapies. Transcranial magnetic stimulation (TMS) is a non-invasive and painless brain stimulation technique that allows researchers to explore and change brain excitability that has shown promising effects in neuropathic pain. However there is not enough evidence of what are the long lasting effects of the different protocols. In this study, 30 SCI subjects with CNP in their hands will participate in the study. The objective is to evaluate the efficacy of real versus sham repetitive transcranial magnetic stimulation (rTMS) and investigate 1) short and long term effects on pain and 2) the behavioral and neurophysiological qualities of responders and non-responders to this treatment.This will be a randomized sham controlled trial with two groups: real or sham high frequency repetitive TMS protocol (20Hz). The protocol will be done daily for two weeks. Clinical, functional and neurophysiological evaluations will be assessed at baseline, post intervention and at 6-week follow up.
Recruiting
Device
25 Neuropathic Pain Clinical Trials Near Me
Spokane, WA
Corpus Christi, TX
Washington, United States
Greenwood Village, CO
More Trial Locations
An interactive map to display trial locations for Northwest Pain Care, Institute of Precision Pain Medicine, International Spine, Pain and Performance Center, Denver Back Pain Specialists, and 70 more locations.
Most Popular References for Neuropathic Pain Clinical Trials
Frequency
Citation
Top Hospitals for Neuropathic Pain Clinical Trials
Location
Active Neuropathic Pain Clinical Trials
All Time Trials for Neuropathic Pain
First Recorded Neuropathic Pain Trial
Trials
Top Treatments for Neuropathic Pain Clinical Trials
Treatment Name
Active Neuropathic Pain Clinical Trials
All Time Trials for Neuropathic Pain
First Recorded Neuropathic Pain Trial
Trials
PNS Therapy plus Conventional Medical Management
1
1
2022
Transcranial Magnetic Stimulation
1
2
2016
Top Cities for Neuropathic Pain Clinical Trials
City
Active Neuropathic Pain Clinical Trials
Top Active Site for Neuropathic Pain Clinical Trials
Trial List
Miami, Florida
9
University of Miami
San Antonio, Texas
6
South Texas Health Care System, San Antonio, TX
Most Recent Neuropathic Pain Clinical Trials
Phase 3 Neuropathic Pain Clinical Trials
Pediatric Neuropathic Pain Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Recently Completed Studies with FDA Approved Treatments for Neuropathic Pain
Treatment
Year
Mechanism of Action
Sponsor
Active Neuropathic Pain Clinical Trials
ETX-018810
2020
Eliem Therapeutics (UK) Ltd.
0
BAY1817080
2020
Bayer
0
LY3016859
2020
Eli Lilly and Company
0
LX9211 high dose
2020
Lexicon Pharmaceuticals
0
NYX-2925 50 mg
2019
Aptinyx
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 2nd, 2021

Last Reviewed: August 17th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.